The U.S. Food and Drug Administration approved updated COVID-19 vaccines but for a more limited group: adults age 65 and ...

CVS and Walgreens are reportedly scaling back access to updated COVID-19 vaccines in several states following new federal ...

This year's updated COVID-19 vaccines have been approved by the U.S. Food and Drug Administration for adults 65 and older and younger people with certain medical conditions that put them at a higher ...

Emergency room data collected by the U.S. Centers for Disease Control and Prevention shows signs of an emerging late-summer spike in covid-19 infections in Arkansas amid uncertainty about how widely ...

The state’s health department is issuing a COVID-19 vaccine health order. CVS and Walgreens are now requiring either a ...

Kennedy on Aug. 27 announced on X that the FDA had given marketing authorization for those at higher risk and that the new Moderna, Pfizer and Novavax COVID-19 vaccines "are available for all patients ...

The FDA approved updated vaccines from Moderna, Pfizer and Novavax for older adults, high risk adults, and some children.

Financially, Novavax, Inc. (NASDAQ:NVAX) reported an unexpected net income of $107 million in Q2 2025, aided by milestone payments, cost reductions, and organizational efficiencies. The corporation ...

Parents will still be able to seek out shots from rival drugmaker Moderna, the other maker of mRNA vaccines, which has full ...

The Food and Drug Administration (FDA) has approved the 2025-2026 formulation of Nuvaxovid ™ (COVID-19 Vaccine, Adjuvanted).

The FDA has approved updated COVID-19 vaccines but restricted their use for many Americans, focusing on age, health, and insurance coverage.

In contrast, the American Academy of Pediatrics recently issued its own guidance based on its review of the evidence. The AAP recommends that all children 6 months to 23 months old and children 2 to ...